SC 13G/A 1 f69261sc13ga.txt AMENDMENT TO SC 13G 1 OMB Number: 3235-0145 Expires: October 31, 2002 Estimated average burden hours per response.....14.90 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 RAYTEL MEDICAL CORPORATION -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $0.001 par value -------------------------------------------------------------------------------- (Title of Class of Securities) 755107-10-9 -------------------------------------------------------------------------------- (CUSIP Number) Check the following box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d - 1(b) [ ] Rule 13d - 1(c) [X] Rule 13d - 1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosure provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 pages 2 CUSIP NO. 755107-10-9 SCHEDULE 13G PAGE 2 OF 5 PAGES (1) NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Richard F. Bader --------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] N/A --------------------------------------------------------------------- (3) SEC USE ONLY --------------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A --------------------------------------------------------------------- (5) SOLE VOTING POWER NUMBER OF 776,767 SHARES -------------------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER OWNED BY 0 EACH -------------------------------------------------------- REPORTING (7) SOLE DISPOSITIVE POWER PERSON WITH 776,767 -------------------------------------------------------- (8) SHARED DISPOSITIVE POWER 0 -------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 776,767 --------------------------------------------------------------------- (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] N/A --------------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.9% --------------------------------------------------------------------- (12) TYPE OF REPORTING PERSON* IN --------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 2 of 5 pages 3 CUSIP NO. 755107-10-9 SCHEDULE 13G PAGE 3 OF 5 PAGES ITEM 1. (a) Name of Issuer: Raytel Medical Corporation (b) Address of Issuer's Principal Executive Offices: 2755 Campus Drive, Suite 200 San Mateo, CA 94403 ITEM 2. (a) Name of Person Filing: Richard F. Bader (b) Address of Principal Business Office or, if none, Residence: Raytel Medical Corporation 2755 Campus Drive, Suite 200 San Mateo, CA 94403 (c) Citizenship: The filing person is a citizen of the United States of America. (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 755107-10-9 ITEM 3. STATUS OF PERSON FILING: Not Applicable ITEM 4. OWNERSHIP (a) Amount Beneficially Owned: 776,767(1) (b) Percent of Class: 8.9%, based on 8,751,775 shares outstanding as of December 31, 2000 (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 776,767(1) (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 776,767(1) (iv) shared power to dispose or to direct the disposition of: 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not Applicable. ------------ (1) Include 346,522 shares subject to options exercisable within 60 days after the date of this statement. Page 3 of 5 pages 4 CUSIP NO. 755107-10-9 SCHEDULE 13G PAGE 4 OF 5 PAGES ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not Applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not Applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not Applicable. ITEM 9. NOTICE OF DISSOLUTION OF THE GROUP Not Applicable. ITEM 10. CERTIFICATION Not applicable. Page 4 of 5 pages 5 CUSIP NO. 755107-10-9 SCHEDULE 13G PAGE 5 OF 5 PAGES SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 9, 2001 /s/ RICHARD F. BADER ------------------------------------ Richard F. Bader Page 5 of 5 pages